The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

The Federal Trade Commission (FTC) is reportedly planning to file an antitrust ... FTC in the form of modifying its business ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.

Explore debt relief solutions to manage & reduce financial burdens effectively. Regain control of your finances & achieve ...

A group of banks led by Wells Fargo & Co launched a US$1.6 billion delayed-draw term loan to help fund Tempur Sealy ...

A man was arrested in Dodge County after officials say he tried to defraud a county resident of more than $81,000.

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

Just weeks into the school year, Texas school districts responded to numerous violent threats, with Nexstar’s Texas stations reporting on threats to at least 20 schools.